Biogen (BIIB) Stock Price, Quote, News & History | Benzinga

Biogen Inc (BIIB) Stock Price, Quote, News & History

BIIBNASDAQ

Trade with Public

Trade with Public

$196.97

3.892.01%

At close: May 27, 5:00 PM EST

$196.97

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$194.11

Close

$196.97

Volume / Avg.

893.05K / 1.16M

Day Range

$194.11 - $199.80

52 Wk Range

121.05 - 205.97

Market Cap

$29.08B

P/E Ratio

20.76

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

3.38%

Days to Cover

3.59

Recent Biogen Inc News

Why Is Biogen Stock Falling Thursday?

Biogen shares slip after mixed Phase 2 Alzheimer's data, but analysts remain optimistic on diranersen's cognitive benefits.

Vandana Singh

Biogen Stock Gains Despite Extended FDA Review For Alzheimer's Therapy

FDA extends review for Biogen's Leqembi Iqlik for early Alzheimer's disease to August 2026.

Vandana Singh

What's Going On With Replimune Stock On Tuesday?

FDA Chief Marty Makary defends decisions amid backlash over drug rejections, internal turmoil and criticism from biotech firms and lawmakers.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

2.59B

Investing Cash Flow (TTM)

-1.53B

Financing Cash Flow (TTM)

-322.70M

Free Cash Flow (TTM)

2.32B

Capital Expenditure (TTM)

-274.50M

Net Change in Cash (TTM)

734.80M

Analyst Trends and Forecast

5

7

Feb

0

0

0

0

Mar

8

4

Apr

3

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$30.78B

PE Ratio (TTM)

20.76

PE Ratio (FWD)

13.83

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.87

PB Ratio (TTM)

1.53

Earnings Yield % (TTM)

4.82%

Earnings Yield % (FWD)

7.23%

EV / EBITDA (TTM)

11.41

Price / EBITDA (TTM)

10.55

Price / Free Cash Flow (TTM)

12.30

Book Value / Share

$126.33

Company Debt

Total Debt

$6.29B

LT Debt

$6.29B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$3.38B

Debt to Equity

0.35

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$194.11

Close

$196.97

Volume / Avg.

893.05K / 1.16M

Day Range

$194.11 - $199.80

52 Wk Range

121.05 - 205.97

Market Cap

$29.08B

P/E Ratio

20.76

Dividend Yield

-

Exchange

NASDAQ

RSI

58

Short Interest

3.38%

Days to Cover

3.59

About

Sector

Health Care

Industry

Biotechnology

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also ge...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Biogen (BIIB) stock?

A

You can purchase shares of Biogen (NASDAQ:BIIB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Biogen (BIIB) competitors?

A

There are no as such competitors for Biogen.

Q

What is the forecast, or price target, for Biogen (BIIB) stock?

A

Biogen has a consensus price target of $203.52.

Q

What is the current price for Biogen (BIIB)?

A

The stock price for Biogen (NASDAQ: BIIB) is $196.97 last updated May 27, 2026 at 4:00 PM EDT.

Q

Does Biogen (BIIB) pay a dividend?

A

There are no upcoming dividends for Biogen.

Q

When is Biogen (NASDAQ:BIIB) reporting earnings?

A

Biogen does not have any upcoming earnings scheduled.

Q

Is Biogen (BIIB) going to split?

A

There is no upcoming split for Biogen.

Q

What sector and industry does Biogen (BIIB) operate in?

A

Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.